Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Nederlands Tijdschrift Voor Geneeskunde|January 25, 2019
[Application of new glucose lowering drugs: DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors]Arianne F E Verburg, Maureen van den Donk, Tjerk Wiersma
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 16, 2010
No negative effects of a multi-factorial, intensified treatment on self-reported health status, treatment satisfaction, and diabetes-related distress in screen-detected type 2 diabetes patients. The ADDITION-Netherlands studyMaureen van den Donk, Kees J Gorter, Guy E Rutten
The European Journal of General Practice|December 16, 2014
New oral anticoagulants for nonvalvular atrial fibrillation in the elderly: Limited applicability in primary careWim Opstelten, Maureen van den Donk, Ton Kuijpers, et al.
Diabetes Care|May 3, 2013
Work stress, sense of coherence, and risk of type 2 diabetes in a prospective study of middle-aged Swedish men and womenAnna-Karin Eriksson, Maureen van den Donk, Agneta Hilding, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 17, 2026
[Epistaxis]Frederike F S Bult, Lotte Firet, Maureen van den Donk, et al.
BMC Public Health|September 14, 2012
Remission of screen-detected metabolic syndrome and its determinants: an observational studyCorine den Engelsen, Kees J Gorter, Philippe L Salomé, et al.
Dermato-Endocrinology|August 8, 2012
Advanced glycation end products measured by skin autofluorescence in a population with central obesityCorine den Engelsen, Maureen van den Donk, Kees J Gorter, et al.
Pageof 4